Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)

被引：0
作者：
Andrea Schwarz
Ilja Demuth
Ulf Landmesser
Arash Haghikia
Maximilian König
Elisabeth Steinhagen-Thiessen
机构：
[1] Charité – Universitätsmedizin Berlin,Department of Endocrinology and Metabolic Diseases (Including Division of Lipid Metabolism)
[2] Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin,Department of Pediatrics
[3] Biology of Aging Working Group,Department of Cardiology
[4] Charité -Universitätsmedizin Berlin,Institute of Clinical Chemistry and Laboratory Medicine
[5] Division of Cardiology,undefined
[6] BCRT – Berlin Institute of Health Center for Regenerative Therapies,undefined
[7] Berlin Institute of Health at Charité-Universitätsmedizin Berlin,undefined
[8] Charité- Universitätsmedizin Berlin,undefined
[9] Campus Benjamin Franklin,undefined
[10] German Centre for Cardiovascular Research (DZHK),undefined
[11] Partner Site Berlin,undefined
[12] University of Rostock,undefined
来源：
Lipids in Health and Disease | / 21卷
关键词：
LDL-cholesterol; Treatment goal achievement; Familial hypercholesterolemia; Lipoprotein (a); Coronary artery disease; Lipid-lowering treatment; Family history;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 256 条
[1]  
Ference BA(2017)Low-density lipoproteins cause atherosclerotic cardiovascular disease 1 Evidence from genetic, epidemiologic, and clinical studies A consensus statement from the European Atherosclerosis Society Consensus Panel Eur Heart J. 38 2459-72
[2]  
Ginsberg HN(2016)Cardiovascular disease in Europe: epidemiological update 2016 Eur Heart J 37 3232-3245
[3]  
Graham I(2019)ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk Atherosclerosis 2019 140-205
[4]  
Ray KK(2010)Lipoprotein(a) as a cardiovascular risk factor: current status Eur Heart J 31 2844-2853
[5]  
Packard CJ(2016)Structure, function, and genetics of lipoprotein (a) J Lipid Res 57 1339-1359
[6]  
Bruckert E(2013)Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society Eur Heart J 34 3478-3490
[7]  
Townsend N(2017)Lipoprotein(a): the revenant Eur Heart J 38 1553-1560
[8]  
Wilson L(2018)The role of lipoprotein (a) in chronic kidney disease J Lipid Res 59 577-585
[9]  
Bhatnagar P(2018)Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials Lancet 392 1311-1320
[10]  
Wickramasinghe K(2020)Lipoprotein(a) and PCSK9 inhibition: clinical evidence Eur Heart J Suppl 22 L53-L56
12345678910